Lior Buchman

Israel Aerospace Industries Ltd. engages in the development, sale, and maintenance of commercial and military aircrafts, missiles, and military electronic products. It operates through the following segments: Aviation, Military Aircraft, Missiles and Space Systems, and Elta Systems Ltd. The Aviation segment engages in the maintenance, renovation, and improvement of aircraft and aircraft engines, and conversion of passenger aircraft into cargo and refueling aircraft, and in the development and manufacture of aviation assemblies for military and commercial aircraft. The Military Aircraft segment engages in the development, manufacture, and sale of unmanned aircraft. The Missiles and Space Systems segment engages in the development, manufacture, and sale of attack and defense missile systems, satellites, and space assemblies. The Elta Systems Ltd segment engages in the military electronics field. The company was founded in 1953 and is headquartered in Lod, Israel.

Maccabi Healthcare Services is an Israeli healthcare company that provides various services to its policyholders. Maccabi Healthcare Services is based in Tel Aviv-Yafo, Israel. The private company offers a service that helps locate emergency centers, consulting and day care centers, medical centers, and dental clinics throughout the country. In addition, the company offers detailed administrative information, a comprehensive health encyclopedia, and entry into Maccabi online services.

Part of Siemens AG, CADVision Medical Technologies is an Israeli company that develops and manufactures a computer-aided diagnostic (CAD) system designed to help radiologists in detecting and analyzing breast cancers in mammography images. The company is based in Jerusalem, Israel. CADVision Medical Technologies was acquired by Siemens Medical Solutions Health Services Corp. from Siemens AG on July 14, 2004.

Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel.

UltraSPECT Ltd. supplies software products for the nuclear medicine imaging practices. It offers Xpress Cardiac a cardiac imaging product; Xpress3.Cardiac a product for three-minute myocardial perfusion SPECT and Xpress/Xact.Bone. The firm products are used in half-dose, half-time, quarter-time and gated scans cardiac applications as well as in attenuation correction cardiac applications. The company was founded by Israel Ohana, Shuli Cohen-Shwartz and Avi Elkayam in 1999 and is headquartered in Raanana, Israel.

Dynamix Pharmaceuticals Ltd. discovers and develops small-molecule drugs for treating cancer and autoimmune disorders. It focuses its discovery on cancer metabolism modulators and type II selective kinase inhibitors. The firm offers DNX-03000 that targets Pyruvate Kinase M2 (PKM2), an enzyme that is a key mediator of cancer metabolism; and DNX-06000 that targets an undisclosed target. The company was founded by Oren M. Becker in 2009 and is headquartered in Rehovot, Israel.

Assuta Medical Centers Ltd. operates a general medical hospital. The private company is based in Tel Aviv, Israel and has subsidiaries in Israel.

Steba Biotech NV is a Dutch company that manufactures cancer drugs. The CEO of the private company is Yehoshua Shemer.

Assuta Hospital IVF Center specializes in female and male infertility treatment. The center was founded in 1987 and is headquartered in Tel Aviv, Israel.

Maccabi-Dent Ltd. is a dental clinic network that is part of the Maccabi Health Services. The Israeli company's website provides information about their dental clinics and allows patients to book appointments directly without a password. The original text is in Hebrew.

OurCrowd Management Ltd (OurCrowd) is a venture capital firm founded in 2013 by Jonathan Medved and Steven Blumgart. The firm is headquartered in Jerusalem, Israel.

Integra Holdings Ltd. operates as a holding company. It invests in the pharmaceutical industry. The company was founded in 2012 and is headquartered in Jerusalem, Israel.

Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel.

FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona.

Nanolabz, Inc. develops a technology system for cancer proton radiation therapy. It develops and sells laser physics targets for the short-pulse laser research and development sector. The company was founded by Steven Malekos, Jesse Adams, and Grant Korgan and is headquartered in Sparks, NV.

Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception.

BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel.

Bayit Balev Ltd. is a leading Israeli company in the field of assisted living for seniors in Israel. Bayit Balev's assisted living facility in Herzliya is located in a pleasant environment, while the one in Jerusalem is situated in the pastoral neighborhood of Rehavia, overlooking the Sakhar Garden and the Nachlaot neighborhood. The private company offers five high-quality and well-maintained assisted living facilities throughout the country. The company is part of the Maccabi Healthcare Services group and provides its residents with a warm and welcoming atmosphere, a sense of community, and a rich cultural life. The company also offers professional and flexible services with 30 years of experience, expertise, and a range of membership options.

Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel.

DreaMed Diabetes Ltd. is a medical technology company based in Petach Tikva, Israel. DreaMed Diabetes is currently commercializing its endo.digital AI-based clinical decision support system for diabetes management. The endo.digital platform has FDA clearance for patients with type 1 diabetes using continuous glucose monitors or self-monitoring blood glucose monitor devices and insulin pumps. The technology also received expanded FDA clearance to include patients with type 1 or type 2 diabetes on multiple daily injections. The Israeli company's first product, an artificial pancreas technology, was licensed to Medtronic and incorporated into its 780g insulin pump technology. The company provides personalized diabetes treatment optimization solutions and was founded in 2014 by Revital Nimri, Tadej Battelino, Eran Atlas, Thomas Danne, and Ido Muller. Eran Atlas has been the CEO since 2014.

OurCrowd Medtech Fund invests in companies located in Israel. The fund targets operating in the fields of medical devices, therapeutics, medical robotics. It provides financing for early stage capital requirements.

OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon.

Resight Ltd is an Israeli company that utilizes AI to enable camera devices to comprehend their surroundings, allowing developers to create Augmented Reality applications. The company is based in Beer Sheva, Israel. Resight is constructing a visual catalog of the world, connecting users, apps, and augmented reality content to physical locations. The company was founded in 2019 by Eran Segal, Omri Stein, Arie Zigler, and Omri Stein has been the CEO since 2019.